Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | APAF1 | O14727 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | XBP1 | P17861 | 1/20 | 0.31 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | GALK1 | P51570 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20820994 | 1.00 | PDK2 (0.32) | PDK2MEN1MAPTKMT2AAPAF1 | |
| SCHEMBL12166355 | 0.91 | L3MBTL1 (0.33) | MEN1MAPTKMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL12166364 | 0.90 | GP6 (0.35) | MEN1MAPTKMT2ALMNAL3MBTL1 | |
| SCHEMBL12166373 | 0.90 | GP6 (0.35) | MEN1MAPTKMT2ALMNAL3MBTL1 | |
| SCHEMBL20821012 | 0.88 | PDK2 (0.40) | PDK2MEN1MAPTKMT2AAPAF1 | |
| SCHEMBL12166380 | 0.88 | GP6 (0.36) | MEN1MAPTKMT2ALMNAL3MBTL1 | |
| SCHEMBL12166348 | 0.87 | L3MBTL1 (0.38) | MEN1MAPTKMT2ANPC1LMNA | |
| SCHEMBL20821009 | 0.86 | PDK2 (0.33) | PDK2MEN1MAPTKMT2AAPAF1 | |
| SCHEMBL17660245 | 0.86 | PDK2 (0.33) | PDK2MEN1MAPTKMT2AAPAF1 | |
| SCHEMBL12166382 | 0.86 | GP6 (0.34) | MEN1MAPTKMT2ALMNAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11760734-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2023-09-19 | — | — | US | disclosed |
| US-10981880-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2021-04-20 | — | — | US | disclosed |
| US-20190169139-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2019-06-06 | — | — | US | disclosed |
| US-20160096809-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2016-04-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190169139-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | SLCO4C1, SLCO2B1, SLCO2A1 | PDK2 2688/4885MEN1 665/4885MAPT 428/4885 |
| US-10981880-B2 | Materials for organic electroluminescent devices | SLCO4C1, SLCO2B1, SLCO2A1 | PDK2 2688/4885MEN1 665/4885MAPT 428/4885 |
| US-20160096809-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | SLCO4C1, SLCO2B1, SLCO2A1 | PDK2 2688/4885MEN1 665/4885MAPT 428/4885 |
| US-11760734-B2 | Materials for organic electroluminescent devices | SLCO4C1, SLCO2B1, SLCO2A1 | PDK2 2688/4885MEN1 665/4885MAPT 428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.